0001209191-21-036629.txt : 20210528 0001209191-21-036629.hdr.sgml : 20210528 20210528180438 ACCESSION NUMBER: 0001209191-21-036629 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210527 FILED AS OF DATE: 20210528 DATE AS OF CHANGE: 20210528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yamada Tadataka CENTRAL INDEX KEY: 0001402530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39231 FILM NUMBER: 21982003 MAIL ADDRESS: STREET 1: COVIDIEN LTD. STREET 2: 15 HAMPSHIRE STREET CITY: MANSFIELD STATE: MA ZIP: 02048 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Passage BIO, Inc. CENTRAL INDEX KEY: 0001787297 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822729751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE COMMERCE SQUARE STREET 2: 2005 MARKET STREET, 39TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 2678660312 MAIL ADDRESS: STREET 1: ONE COMMERCE SQUARE STREET 2: 2005 MARKET STREET, 39TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-27 0 0001787297 Passage BIO, Inc. PASG 0001402530 Yamada Tadataka TWO COMMERCE SQUARE 200 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 1 0 0 0 Director Stock Option (Right to Buy) 13.83 2021-05-27 4 A 0 16918 0.00 A 2031-05-26 Common Stock 16918 16918 D The stock option vests as of 1/12 of the total shares monthly beginning on June 27, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Edgar Cale, Attorney-in-Fact 2021-05-28